Infectious Disease Diagnosis & Treatment Market Research Report-  Asia Pacific Forecast to 2027

Asia Pacific Infectious Disease Diagnosis & Treatment Market Research Report, By Applications (AIDS, Tuberculosis (TB), Hepatitis, HPV, And Others), By Treatment (Antibiotics, Antivirals, Antifungals, Anti-Parasitic, Alternative Medicine And Others), By Diagnostic Techniques (Immunoassays, PCR, Cell Cultures And Other), By End Users (Hospitals, Clinics, Reference Labs And Others)- Forecast Till 2027

ID: MRFR/MED/0814-HCR | October 2022 | Region: Asia-Pacific | 80 Pages         

Infectious Disease Diagnosis & Treatment Market Overview


The infectious disease diagnosis & treatment market is anticipated to grow substantially in the years to come. The infectious illness diagnosis and treatment market value was estimated at around USD 179.58 Billion in the year 2018. infectious disease diagnosis & treatment market is expected to grow at a CAGR (Compound Annual Growth Rate) of about 7.84% in the coming years.


Bacteria, viruses, fungi, and parasites are all responsible for infectious disorders. These illnesses can be spread by insects, animals, contaminated food or drink, or exposure to an infected environment. The market is predicted to escalate due to the rising incidence of infectious illnesses and increased awareness of these diseases. According to a World Health Organization (WHO) report, almost 50,000 people die every day due to infectious diseases.


Covid-19 Analysis


With the rise of the Covid-19 impact, many large-scale businesses and industries suffered, except healthcare and life support products. The lockdown and physical distancing protocols have affected millions of small and big business institutions alike. The infectious illnesses diagnosis & treatment market saw a slight downfall due to the lockdown and physical distancing.


However, the key companies have adopted measures to expand the distribution of infectious illnesses treatment and diagnosis equipment across the globe. Moreover, people are growing aware of infectious diseases, and the price of pharmaceutical products is increasing. Hence, these factors are expected to boost the infectious disease diagnosis & treatment market value in the years to come.


Market Dynamics 


Drivers


Infectious illness prevalence in both established and emerging nations would boost the infectious disease diagnosis & treatment market growth. The rising number of prescriptions for infectious illness diagnostic tests is due to diagnosing and managing such disorders. Over the forecast period, these factors, together with the increasing tendency toward preventative care, are projected to increase demand for infectious disease diagnosis & treatment market.


Opportunities 


Due to multiple major and minor significant players, the infectious illnesses treatment & diagnosis market seems fragmented. These market participants attempt to acquire a competitive edge through strategic initiatives such as partnership, acquisition, expansion, cooperation, and product and technology launches. Significant efforts are being made in R&D to produce unique diagnoses & treatment options.


Restraints 


A few factors may inhibit the growth of the infectious disease diagnosis & treatment market share. The development of the infectious illness treatment market is likely to be hampered by stringent government restrictions and a lack of information about treatment choices in developing nations. Inadequate reimbursement is a key stumbling block to the infectious disease diagnostics market's development.


Challenges 


There are various concerns with the market that may challenge the key players of the infectious disease diagnosis & treatment market. This includes the cost of the diagnosis and treatment solutions. High treatment and maintenance costs for infectious diseases and a lack of infrastructure in medium and low-income nations may limit the expansion of the market. Most diagnostic companies have a significant challenge in commercializing their tests, convincing their health insurance to pay for them.


Cumulative Growth Analysis


The infectious disease diagnosis & treatment market is anticipated to grow substantially in the years to come. The infectious illness market value was estimated at around USD 179.58 Billion in 2018 and is expected to grow at a CAGR of about 7.84% in the coming years.


Value Chain Analysis


During the infectious disease diagnosis & treatment market forecast, demand for diagnostics is likely to be driven by the expanding trend of preventive medicine. To strengthen Covid-19 preventive and control efforts, large-scale population-based testing is necessary. Infectious illness diagnostics performs these tests. Hence, it is likely to have a favorable influence on infectious disease diagnosis & treatment market.


Developing economies such as India, South Korea, Brazil, and Mexico will likely provide significant infectious illness diagnostics market participants with new growth prospects. The high illness incidence, big patient population, better healthcare infrastructure, increasing disposable money, and growing medical tourism in these nations contribute to this. Aside from the aforementioned characteristics, the Asia Pacific region has grown as a flexible and business-friendly center due to less strict rules and data requirements.


Segment Overview


The global infectious disease diagnosis & treatment market is classified into many segments such as disease types, treatment, and end-user. Listed below are the infectious illness treatment & diagnosis market segments:


By Disease Type



  • Bacterial diseases

  • Viral diseases

  • Fungal diseases

  • Parasitic diseases

  • Others


By Treatment



  • Antibiotics

  • Antivirals

  • Antifungals

  • Anti-parasitic

  • Others


By End-user



  • Hospitals & clinics

  • Ambulatory Care Centers

  • Others


Regional Analysis


The regional division of the infectious disease diagnosis & treatment market analysis comprises North America, Europe, Asia Pacific, and the rest of the world. The Americas are expected to dominate the infectious disease treatment market due to a rising patient population suffering from different kinds of infectious illnesses and a growing number of government efforts to prevent contagious diseases in the area.


Due to rising awareness and an increasing patient population suffering from severe infectious diseases, Europe is expected to hold the second-largest position in the infectious disease diagnosis & treatment market. According to the WHO, 14 million people in Europe are infected with hepatitis C as of 2018. Due to the huge patient population suffering from bacterial infectious illnesses and the increasing number of activities conducted by governments and private organizations to raise awareness about infectious diseases, Asia-Pacific is predicted to be the fastest-growing regional market.


According to a May 2018 study released by the National Center for Biotechnology Information (NCBI), meningitis and pneumonia account for roughly 22% of mortality among children under five in India. Because of the expanding patient population suffering from various infectious illnesses, the infectious disease diagnosis & treatment market in the Middle East and Africa is predicted to rise slowly.


Competitive Landscape 


The infectious disease diagnosis & treatment industry is dominated by a few companies that play a vital role in the market growth. These infectious illnesses diagnosis and treatment provider companies are called key companies of the market. They contribute to the largest share of the infectious disease diagnosis & treatment market profit.


The companies account for the market profits by adopting various infectious disease diagnosis & treatment market trends such as joint ventures, product launches, company expansions, and procurements. They provide innovative solutions for patients suffering from infectious illnesses.


Key Players


Below are the key companies that offer infectious illness diagnosis and treatment solutions in the global infectious disease diagnosis & treatment market, along with the location of their headquarters:



  • Pfizer Inc. (US)

  • Bristol-Myers Squibb Company (US)

  • Janssen Global Services LLC (US)

  • Eli Lilly and Company (US)

  • Ortho Clinical Diagnostics (US)

  • Merck & Co. Inc. (US)

  • AbbVie Inc. (US)

  • Hoffmann-La Roche Ltd (Switzerland)

  • Novartis AG (Switzerland)

  • Aurobindo Pharma (India)

  • Bayer AG (Germany)

  • Reddy's Laboratories (India)

  • Sanofi (France)

  • Cipla Inc. (India)

  • Seegene Inc. (South Korea)

  • ABACUS Diagnostica Oy (Finland)

  • GlaxoSmithKline PLC (UK)

  • Alkem Labs (India)

  • Astellas Pharma Inc. (Japan)


 


The infectious disease diagnosis & treatment market is anticipated to grow substantially in the years to come. The infectious illness diagnosis and treatment market value was estimated at around USD 179.58 Billion in the year 2018. infectious disease diagnosis & treatment market is expected to grow at a CAGR (Compound Annual Growth Rate) of about 7.84% in the coming years.


Bacteria, viruses, fungi, and parasites are all responsible for infectious disorders. These illnesses can be spread by insects, animals, contaminated food or drink, or exposure to an infected environment. The market is predicted to escalate due to the rising incidence of infectious illnesses and increased awareness of these diseases. According to a World Health Organization (WHO) report, almost 50,000 people die every day due to infectious diseases.


Covid-19 Analysis


With the rise of the Covid-19 impact, many large-scale businesses and industries suffered, except healthcare and life support products. The lockdown and physical distancing protocols have affected millions of small and big business institutions alike. The infectious illnesses diagnosis & treatment market saw a slight downfall due to the lockdown and physical distancing.


However, the key companies have adopted measures to expand the distribution of infectious illnesses treatment and diagnosis equipment across the globe. Moreover, people are growing aware of infectious diseases, and the price of pharmaceutical products is increasing. Hence, these factors are expected to boost the infectious disease diagnosis & treatment market value in the years to come.


Market Dynamics 


Drivers


Infectious illness prevalence in both established and emerging nations would boost the infectious disease diagnosis & treatment market growth. The rising number of prescriptions for infectious illness diagnostic tests is due to diagnosing and managing such disorders. Over the forecast period, these factors, together with the increasing tendency toward preventative care, are projected to increase demand for infectious disease diagnosis & treatment market.


Opportunities 


Due to multiple major and minor significant players, the infectious illnesses treatment & diagnosis market seems fragmented. These market participants attempt to acquire a competitive edge through strategic initiatives such as partnership, acquisition, expansion, cooperation, and product and technology launches. Significant efforts are being made in R&D to produce unique diagnoses & treatment options.


Restraints 


A few factors may inhibit the growth of the infectious disease diagnosis & treatment market share. The development of the infectious illness treatment market is likely to be hampered by stringent government restrictions and a lack of information about treatment choices in developing nations. Inadequate reimbursement is a key stumbling block to the infectious disease diagnostics market's development.


Challenges 


There are various concerns with the market that may challenge the key players of the infectious disease diagnosis & treatment market. This includes the cost of the diagnosis and treatment solutions. High treatment and maintenance costs for infectious diseases and a lack of infrastructure in medium and low-income nations may limit the expansion of the market. Most diagnostic companies have a significant challenge in commercializing their tests, convincing their health insurance to pay for them.


Cumulative Growth Analysis


The infectious disease diagnosis & treatment market is anticipated to grow substantially in the years to come. The infectious illness market value was estimated at around USD 179.58 Billion in 2018 and is expected to grow at a CAGR of about 7.84% in the coming years.


Value Chain Analysis


During the infectious disease diagnosis & treatment market forecast, demand for diagnostics is likely to be driven by the expanding trend of preventive medicine. To strengthen Covid-19 preventive and control efforts, large-scale population-based testing is necessary. Infectious illness diagnostics performs these tests. Hence, it is likely to have a favorable influence on infectious disease diagnosis & treatment market.


Developing economies such as India, South Korea, Brazil, and Mexico will likely provide significant infectious illness diagnostics market participants with new growth prospects. The high illness incidence, big patient population, better healthcare infrastructure, increasing disposable money, and growing medical tourism in these nations contribute to this. Aside from the aforementioned characteristics, the Asia Pacific region has grown as a flexible and business-friendly center due to less strict rules and data requirements.


Segment Overview


The global infectious disease diagnosis & treatment market is classified into many segments such as disease types, treatment, and end-user. Listed below are the infectious illness treatment & diagnosis market segments:


By Disease Type



  • Bacterial diseases

  • Viral diseases

  • Fungal diseases

  • Parasitic diseases

  • Others


By Treatment



  • Antibiotics

  • Antivirals

  • Antifungals

  • Anti-parasitic

  • Others


By End-user



  • Hospitals & clinics

  • Ambulatory Care Centers

  • Others


Regional Analysis


The regional division of the infectious disease diagnosis & treatment market analysis comprises North America, Europe, Asia Pacific, and the rest of the world. The Americas are expected to dominate the infectious disease treatment market due to a rising patient population suffering from different kinds of infectious illnesses and a growing number of government efforts to prevent contagious diseases in the area.


Due to rising awareness and an increasing patient population suffering from severe infectious diseases, Europe is expected to hold the second-largest position in the infectious disease diagnosis & treatment market. According to the WHO, 14 million people in Europe are infected with hepatitis C as of 2018. Due to the huge patient population suffering from bacterial infectious illnesses and the increasing number of activities conducted by governments and private organizations to raise awareness about infectious diseases, Asia-Pacific is predicted to be the fastest-growing regional market.


According to a May 2018 study released by the National Center for Biotechnology Information (NCBI), meningitis and pneumonia account for roughly 22% of mortality among children under five in India. Because of the expanding patient population suffering from various infectious illnesses, the infectious disease diagnosis & treatment market in the Middle East and Africa is predicted to rise slowly.


Competitive Landscape 


The infectious disease diagnosis & treatment industry is dominated by a few companies that play a vital role in the market growth. These infectious illnesses diagnosis and treatment provider companies are called key companies of the market. They contribute to the largest share of the infectious disease diagnosis & treatment market profit.


The companies account for the market profits by adopting various infectious disease diagnosis & treatment market trends such as joint ventures, product launches, company expansions, and procurements. They provide innovative solutions for patients suffering from infectious illnesses.


Key Players


Below are the key companies that offer infectious illness diagnosis and treatment solutions in the global infectious disease diagnosis & treatment market, along with the location of their headquarters:



  • Pfizer Inc. (US)

  • Bristol-Myers Squibb Company (US)

  • Janssen Global Services LLC (US)

  • Eli Lilly and Company (US)

  • Ortho Clinical Diagnostics (US)

  • Merck & Co. Inc. (US)

  • AbbVie Inc. (US)

  • Hoffmann-La Roche Ltd (Switzerland)

  • Novartis AG (Switzerland)

  • Aurobindo Pharma (India)

  • Bayer AG (Germany)

  • Reddy's Laboratories (India)

  • Sanofi (France)

  • Cipla Inc. (India)

  • Seegene Inc. (South Korea)

  • ABACUS Diagnostica Oy (Finland)

  • GlaxoSmithKline PLC (UK)

  • Alkem Labs (India)

  • Astellas Pharma Inc. (Japan)


 



Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

The Americas are expected to dominate the infectious disease treatment market due to a rising patient population suffering from different kinds of infectious illnesses and a growing number of government efforts to prevent the spread of infectious diseases in the area.

The major key players in the infectious illnesses diagnosis & treatment market include Pfizer Inc. (US), Bristol-Myers Squibb Company (US), Janssen Global Services LLC (US), Eli Lilly and Company (US), Merck & Co. Inc. (US), AbbVie Inc. (US), Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Aurobindo Pharma (India), Seegene Inc. (South Korea), ABACUS Diagnostica Oy (Finland), Bayer AG (Germany), Dr. Reddy's Laboratories (India), Sanofi (France), Cipla Inc. (India), GlaxoSmithKline PLC (UK), Alkem Labs (India), and Astellas Pharma Inc. (Japan).

The forecast period for the infectious disease diagnosis & treatment market research report is 2022 to 2027.

The global infectious illnesses diagnosis & treatment industry is anticipated to grow at a CAGR of 7.84%.